Effect of clot removal and the different incidence of vasospasm between clipping and GDC

Neurological Research

Volumn 28, Issue 4, 2006, Pages 424-430

  Ohkuma, Hiroki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Aneurysmal neck clipping; Cerebral aneurysm; Cerebral vasospasm; Endovascular treatment; Subarachnoid hemorrhage

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; NIMODIPINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANEURYSM CLIP; ANEURYSM SURGERY; BLOOD CLOTTING; BRAIN VASOSPASM; CLINICAL TRIAL; COIL EMBOLIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOVASCULAR SURGERY; HUMAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBARACHNOID HEMORRHAGE; THROMBOSIS PREVENTION; TREATMENT FAILURE; VASOSPASM;

ANIMALS; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; HUMANS; INCIDENCE; INTRACRANIAL ANEURYSM; SURGICAL INSTRUMENTS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VASOSPASM, INTRACRANIAL;

EID: 33745657617     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X115026     Document Type: Review

References (59)

1. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9
2. Mizukami M, Takemae T, Tazawa T, et al. Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture. Neurosurgery 1980; 7: 583-586
3. Nosko M, Weir BK, Lunt A, et al. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg 1987; 66: 416-422
4. Handa Y, Weir BK, Nosko M, et al. The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg 1987; 67: 558-564
5. Ljunggren B, Brandt L, Kagstrom E, et al. Results of early operations for ruptured aneurysms. J Neurosurg 1981; 54: 473-479
6. Taneda M. Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg 1982; 57: 622-628
7. Mizukami M, Kawase T, Usami T, et al. Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 1982; 10: 301-307
8. Yamamoto I, Hara M, Ogura K, et al. Early operation for ruptured intracranial aneurysms: Comparative study with computed tomography. Neurosurgery 1983; 12: 169-174
9. Murayama Y, Malisch T, Guglielmi G, et al. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: Report on 69 cases. J Neurosurg 1997; 87: 830-835
10. Weir B, Rothberg C, Grace M, et al. Relative prognostic significance of vasospasm following subarachnoid hemorrhage. Can J Neurol Sci 1975; 2: 109-114
11. Macdonald RL, Wallace MC, Coyne TJ. The effect of surgery on the severity of vasospasm. J Neurosurg 1994; 80: 433-439
12. Kawakami Y, Shimamura Y. Cisternal drainage after early operation of ruptured intracranial aneurysm. Neurosurgery 1987; 20: 8-14
13. Sakaki S, Ohta S, Kuwabara H, et al. The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms. Acta Neurochir (Wien) 1987; 88: 87-94
14. Yamamoto I, Shimoda M, Yamada S, et al. Indications for cisternal drainage in conjunction with early surgery in ruptured aneurysms and timing of its discontinuation. Neurol Med Chir (Tokyo) 1989; 29: 407-413
15. Inagawa T, Kamiya K, Matsuda Y. Effect of continuous cisternal drainage on cerebral vasospasm. Acta Neurochir (Wien) 1991; 112: 28-36
16. Kasuya H, Shimizu T, Kagawa M. The effect of continuous drainage of cerebrospinal fluid in patients with subarachnoid hemorrhage: A retrospective analysis of 108 patients. Neurosurgery 1991; 28: 56-59
17. Alksne JF, Branson PJ, Bailey M. Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin. Neurosurgery 1986; 19: 20-25
18. Alksne JF, Branson PJ, Bailey M. Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin. Neurosurgery 1988; 23: 335-337
19. Findlay JM, Weir BK, Steinke D, et al. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 1988; 69: 723-735
20. Findlay JM, Weir BK, Gordon P, et al. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 1989; 24: 491-498
21. Findlay JM, Weir BK, Kanamaru K, et al. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 1990; 26: 201-206
22. Hariton GB, Findlay JM, Weir BK, et al. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery 1993; 33: 691-696
23. Seifert V, Eisert WG, Stolke D, et al. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 1989; 25: 590-598
24. Chung WY, Lee LS. The effect of tissue plasminogen activator (tPA) on cerebral vasospasm in canine subarachnoid hemorrhage. Zhonghua Yi Xue Za Zhi (Taipei) 1993; 52: 298-306
25. Yamamoto Y, Clower BR, Haining JL, et al. Effect of tissue plasminogen activator on intimal platelet accumulation in cerebral arteries after subarachnoid hemorrhage in cats. Stroke 1991; 22: 780-784
26. Pennica D, Holmes WE, Kohr WJ, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301: 214-221
27. Findlay JM, Weir BK, Kassell NF, et al. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 181-188
28. Ohman J, Servo A, Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 197-201
29. Zabramski JM, Spetzler RF, Lee KS, et al. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 189-196
30. Mizoi K, Yoshimoto T, Fujiwara S, et al. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: Preliminary report. Neurosurgery 1991; 28: 807-812
31. Stolke D, Seifert V. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: Preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 1992; 30: 877-881
32. Sasaki T, Ohta T, Kikuchi H, et al. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1994; 35: 597-604
33. Mizoi K, Yoshimoto T, Takahashi A, et al. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 1993; 78: 430-437
34. Seifert V, Stolke D, Zimmermann M, et al. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta Neurochir (Wien) 1994; 128: 137-143
35. Usui M, Saito N, Hoya K, et al. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 1994; 34: 235-244
36. Findlay JM, Kassell NF, Weir BK, et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995; 37: 168-176
37. Kodama N, Sasaki T, Kawakami M, et al. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol 2000; 53: 110-117
38. Sasaki T, Kodama N, Kawakami M, et al. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: A study of urokinase concentration and the fibrinolytic system. Stroke 2000; 31: 1256-1262
39. Eskridge JM, Song JK. Endovascular embolization of 150 basilar tip aneurysms with Guglielmi detachable coils: Results of the Food and Drug Administration multicenter clinical trial. J Neurosurg 1998; 89: 81-86
40. Casasco A, George B. Endovascular treatment of saccular intracranial aneurysm. J Neurosurg Sci 1998; 42 (1 Suppl. 1): 125-126
41. Debrun GM, Aletich VA, Kehrli P, et al. Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: The preliminary University of Illinois at Chicago experience. Neurosurgery 1998; 43: 1281-1295
42. Bernardini GL, Mayer SA, Kossoff SB, et al. Anticoagulation and induced hypertension after endovascular treatment for ruptured intracranial aneurysms. Crit Care Med 2001; 29: 641-644
43. Aiyagari V, Cross DT 3rd, Deibert E, et al. Safety of hemodynamic augmentation in patients treated with Guglielmi detachable coils after acute aneurysmal subarachnoid hemorrhage. Stroke 2001; 32: 1994-1997
44. Vallee JN, Aymard A, Vicaut E, et al. Endovascular treatment of basilar tip aneurysms with Guglielmi detachable coils: Predictors of immediate and long-term results with multivariate analysis 6-year experience. Radiology 2003; 226: 867-879
45. Kinugasa K, Kamata I, Hirotsune N, et al. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. J Neurosurg 1995; 83: 34-41
46. Hamada J, Kai Y, Morioka M, et al. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: A prospective randomized study. Stroke 2003; 34: 2549-2554
47. Yalamanchili K, Rosenwasser RH, Thomas JE, et al. Frequency of cerebral vasospasm in patients treated with endovascular occlusion of intracranial aneurysms. AJNR Am J Neuroradiol 1998; 19: 553-558
48. Collice M, D'Aliberti G, Arena O, et al. Multidisciplinary (surgical and endovascular) approach to intracranial aneurysms. J Neurosurg Sci 1998; 42: 131-140
49. Gruber A, Ungersbock K, Reinprecht A, et al. Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 1998; 42: 258-267
50. Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage; A comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003; 98: 319-325
51. Inagawa T, Ohbayahi N, Hada H. Rapid spontaneous diminution of cisternal blood on computed tomography in patients with subarachnoid hemorrhage. Surg Neurol 1995; 44: 356-363
52. Inagawa T, Ohbayashi N, Kumano K. Effect of rapid spontaneous diminution of subarachnoid hemorrhage on cerebral vasospasm. Surg Neurol 1995; 43: 25-30
53. Yundt KD, Grubb RL, Jr, Diringer MN, et al. Cerebral hemodynamic and metabolic changes caused by brain retraction after aneurysmal subarachnoid hemorrhage. Neurosurgery 1997; 40: 442-450
54. Chang HS, Hongo K, Nakagawa H. Adverse effects of limited hypotensive anesthesia on the outcome of patients with subarachnoid hemorrhage. J Neurosurg 2000; 92: 971-975
55. Critchley GR, O'Neill KS, Bell BA. Cerebral blood flow and tissue oxygenation monitoring during aneurysm surgery. Neurol Res 1998; 20(Suppl. 1): S44-S47
56. Schaller C, Zentner J. Vasospastic reactions in response to the transsylvian approach. Surg Neurol 1998; 49: 170-175
57. Byrne JV, Sohn MJ, Molyneux AJ, et al. Five-year experience in using coil embolization for ruptured intracranial aneurysms: Outcomes and incidence of late rebleeding. J Neurosurg 1999; 90: 656-663
58. Koivisto T, Vanninen R, Hurskainen H, et al. Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomized study. Stroke 2000; 31: 2369-2377
59. Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005; 366: 809-817